AAPL   329.68 (+2.28%)
MSFT   186.30 (+1.85%)
FB   230.74 (+1.97%)
GOOGL   1,441.77 (+1.94%)
CGC   16.68 (+0.30%)
BABA   219.97 (+0.89%)
MU   54.37 (+6.15%)
GE   8.10 (+4.65%)
TSLA   877.08 (+1.47%)
F   7.37 (+12.18%)
BA   213.48 (+15.83%)
AAPL   329.68 (+2.28%)
MSFT   186.30 (+1.85%)
FB   230.74 (+1.97%)
GOOGL   1,441.77 (+1.94%)
CGC   16.68 (+0.30%)
BABA   219.97 (+0.89%)
MU   54.37 (+6.15%)
GE   8.10 (+4.65%)
TSLA   877.08 (+1.47%)
F   7.37 (+12.18%)
BA   213.48 (+15.83%)
AAPL   329.68 (+2.28%)
MSFT   186.30 (+1.85%)
FB   230.74 (+1.97%)
GOOGL   1,441.77 (+1.94%)
CGC   16.68 (+0.30%)
BABA   219.97 (+0.89%)
MU   54.37 (+6.15%)
GE   8.10 (+4.65%)
TSLA   877.08 (+1.47%)
F   7.37 (+12.18%)
BA   213.48 (+15.83%)
AAPL   329.68 (+2.28%)
MSFT   186.30 (+1.85%)
FB   230.74 (+1.97%)
GOOGL   1,441.77 (+1.94%)
CGC   16.68 (+0.30%)
BABA   219.97 (+0.89%)
MU   54.37 (+6.15%)
GE   8.10 (+4.65%)
TSLA   877.08 (+1.47%)
F   7.37 (+12.18%)
BA   213.48 (+15.83%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 XBiotechBioSpecifics TechnologiesInnate PharmaCrinetics PharmaceuticalsArdelyx
SymbolNASDAQ:XBITNASDAQ:BSTCOTCMKTS:IPHYFNASDAQ:CRNXNASDAQ:ARDX
Price Information
Current Price$14.00$61.16$6.23$15.89$6.78
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.51.91.21.41.6
Analysis Score3.53.53.33.53.5
Community Score3.22.62.82.32.7
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.01.01.0
Earnings & Valuation Score0.62.50.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$23.00$90.00$11.00$35.00$12.00
% Upside from Price Target64.29% upside47.16% upside76.57% upside120.21% upside76.99% upside
Trade Information
Market Cap$401.04 million$429.30 million$489.30 million$526.91 million$622.06 million
Beta1.440.870.571.271.89
Average Volume170,49529,721628142,172670,427
Sales & Book Value
Annual RevenueN/A$38.19 million$96.12 million$1.19 million$5.28 million
Price / SalesN/A11.755.09438.75114.19
Cashflow$16.28 per share$3.53 per shareN/AN/AN/A
Price / Cash0.8617.33N/AN/AN/A
Book Value$18.20 per share$16.96 per share$4.23 per share$4.84 per share$2.10 per share
Price / BookN/A3.611.473.283.23
Profitability
Net Income$668.63 million$24.47 million$-23,250,000.00$-50,420,000.00$-94,940,000.00
EPSN/A$3.33N/A($2.09)($1.47)
Trailing P/E RatioN/A18.370.00N/AN/A
Forward P/E Ratio107.6911.22∞N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A61.80%N/AN/A-1,403.90%
Return on Equity (ROE)218.15%21.37%N/A-47.28%-77.23%
Return on Assets (ROA)205.36%20.97%N/A-42.59%-48.46%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.04%0.26%
Current Ratio25.20%36.72%1.95%10.89%9.76%
Quick Ratio25.20%36.72%1.95%10.89%9.76%
Ownership Information
Institutional Ownership Percentage15.21%63.09%N/A62.97%86.08%
Insider Ownership Percentage30.98%16.39%N/A7.40%15.31%
Miscellaneous
Employees5661954788
Shares Outstanding28.85 million7.34 million78.54 million32.85 million88.93 million
Next Earnings Date6/11/2020 (Estimated)8/14/2020 (Estimated)6/9/2020 (Estimated)8/11/2020 (Estimated)8/14/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.